RR

Russell P. Rother

AP Alexion Pharmaceuticals: 36 patents #1 of 226Top 1%
OF Oklahoma Medical Research Foundation: 2 patents #57 of 184Top 35%
SP Selexys Pharmaceuticals: 2 patents #5 of 5Top 100%
📍 Oklahoma City, OK: #7 of 1,463 inventorsTop 1%
🗺 Oklahoma: #140 of 12,736 inventorsTop 2%
Overall (All Time): #85,963 of 4,157,543Top 3%
38
Patents All Time

Issued Patents All Time

Showing 1–25 of 38 patents

Patent #TitleCo-InventorsDate
11807678 Methods and compositions for treating complement-associated disorders 2023-11-07
11407821 Anti-C5A antibodies Douglas L. Sheridan, Paul P. Tamburini, Yuchun Zhang 2022-08-09
11112402 Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders Mayur Movalia, Andrea Illingworth, Susan Faas McKnight 2021-09-07
10703809 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Leonard Bell, Mark Evans 2020-07-07
10590189 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Leonard Bell, Mark Evans 2020-03-17
10450370 Anti-C5a antibodies Douglas L. Sheridan, Paul P. Tamburini, Yuchun Zhang 2019-10-22
10126293 Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders Mayur Movalia, Andrea Illingworth, Susan Faas McKnight 2018-11-13
9963503 Methods of producing anti-C5a antibodies Douglas L. Sheridan, Paul P. Tamburini, Yuchun Zhang 2018-05-08
9862767 Therapeutic methods using anti-CD200 antibodies Yan Yan 2018-01-09
9771418 Methods for treating complement-associated disorders Camille Bedrosian, Stephen P. Squinto, Leonard Bell 2017-09-26
9732149 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Leonard Bell, Mark Evans 2017-08-15
9725504 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Leonard Bell, Mark Evans 2017-08-08
9718880 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Leonard Bell, Mark Evans 2017-08-01
RE46323 Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses Susan Faas McKnight 2017-02-28
9469690 Methods of treating complement-associated disorders with anti-C5a antibodies Douglas L. Sheridan, Paul P. Tamburini, Yuchun Zhang 2016-10-18
9447176 Methods and compositions for treating complement-associated disorders Camille Bedrosian, Stephen P. Squinto, Leonard Bell 2016-09-20
9434784 Nucleic acids encodng anti-C5A antibodies Douglas L. Sheridan, Paul P. Tamburini, Yuchun Zhang 2016-09-06
9388235 Methods and compositions for the treatment of antibody mediated neuropathies Susan Halstead, Hugh Willison 2016-07-12
9371378 Anti-C5a antibodies Douglas L. Sheridan, Paul P. Tamburini, Yuchun Zhang 2016-06-21
9309310 Nucleic acids encoding anti-C5a antibodies Douglas L. Sheridan, Paul P. Tamburini, Yuchun Zhang 2016-04-12
9221901 Methods of treating complement-associated disorders with anti-C5a antibodies Douglas L. Sheridan, Paul P. Tamburini, Yuchun Zhang 2015-12-29
9085623 Therapeutic methods using anti-CD200 antibodies Yan Yan 2015-07-21
9068001 Anti-P-selectin antibodies Scott Rollins, Richard Alvarez, Rodger P. McEver, Ziad S. Kawar 2015-06-30
9011852 Anti-C5a antibodies Douglas L. Sheridan, Paul P. Tamburini, Yuchun Zhang 2015-04-21
8945565 Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies Scott Rollins, Richard Alvarez, Rodger P. McEver, Ziad S. Kawar 2015-02-03